Organ-on-a-Chip: Novel In Vitro Model
for Drug Discovery
6
Geeta Aggarwal, Gaurav Kaithwas, Manjari Singh,
and Ramesh K. Goyal
Abstract
In conventional drug discovery process, the attrition in clinical development as a
consequence of late clinical trial failure has been very high. One of the main
reasons for high attrition rate during clinical trials is the limitation of animal
models used for preclinical testing of drugs, which are not able to clearly predict
drug response in patients. In spite of advancements in use of preclinical and
in vitro models, viz., cell cultures, computational models, animals, and
humanized animals during drug discovery process, there is a need to develop a
human-specific model to bridge this gap between animal-based models and
human clinical trials.
In vitro disease models can provide an excellent alternative to the animal
models as they minimize the use of animals and understand the cellular and
molecular aspects of various diseases. One of the important techniques for
development of three-dimensional (3D) in vitro model is 3D bioprinting, which
makes realistic in vitro disease models and mimics the actual cellular arrangement
of any human tissue or organ. Organ-on-a-chip as 3D in vitro model has shown its
potential to understand the disease mechanism along with evaluation of new
therapeutic compounds. Further, multiple organs on a chip are utilized to under-
stand drug–drug interactions and pharmacokinetic profile of new drugs and thus
show potential to predict safety and efficacy of drug in patients in a more realistic
G. Aggarwal · R. K. Goyal (*)
Delhi Pharmaceutical Sciences and Research University, New Delhi, India
e-mail: goyalrk@gmail.com
G. Kaithwas
Babasahem Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India
M. Singh
Department of Pharmaceutical Sciences, Assam University, Silchar, Assam, India
# The Author(s), under exclusive license to Springer Nature Singapore Pte
Ltd. 2022
R. C. Sobti, N. S. Dhalla (eds.), Biomedical Translational Research,
https://doi.org/10.1007/978-981-16-9232-1_6
73